MXRX — Med X Cashflow Statement
0.000.00%
HealthcareMicro Cap
Annual cashflow statement for Med X, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | R2021 December 31st | 2022 December 31st | |
---|---|---|---|
Period Length: | 12 M | 12 M | 12 M |
Source: | PROSPECTUS/A | PROSPECTUS | PROSPECTUS |
Standards: | USG | USG | USG |
Status: | Final | Final | Final |
Net Income/Starting Line | -3.54 | -4.97 | -7.34 |
Depreciation | |||
Non-Cash Items | 0.367 | 0.752 | 1.92 |
Unusual Items | |||
Other Non-Cash Items | |||
Changes in Working Capital | -0.24 | -0.282 | 0.511 |
Change in Accounts Receivable | |||
Change in Inventories | |||
Change in Prepaid Expenses | |||
Change in Payable / Accrued Expenses | |||
Cash from Operating Activities | -3.3 | -4.46 | -4.88 |
Capital Expenditures | -0.004 | -0.002 | -0.049 |
Purchase of Fixed Assets | |||
Other Investing Cash Flow Items | 0 | 0.036 | 0 |
Sale of Fixed Assets | |||
Cash from Investing Activities | -0.004 | 0.034 | -0.049 |
Net Issuance / Retirement of Stock | |||
Net Issuance / Retirement of Debt | |||
Cash from Financing Activities | 3.83 | 5.04 | 3.77 |
Beginning Cash Balance | |||
Ending Cash Balance | |||
Net Change in Cash | 0.528 | 0.614 | -1.16 |